Data / Form D filings / Lattice Biotech, LLC
Lattice Biotech, LLC: Form D filings
Lattice Biotech, LLC, a pharmaceuticals company in Athens, OH, filed 2 Form D notices with the SEC between 2016 and 2017. The latest, on February 28, 2017, reports $512,000 sold of a $8 million offering to 25 investors.
Find out what Lattice Biotech, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 340 West State Street, Suite 212, Athens, OH, 45701
- Phone
- (614) 915-0865
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 504
- SEC identifier (CIK)
- 1667964
The full lists. Form D filings in Ohio: 1,071 rows, $53.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 28, 2017 | Amendment | $8,000,000 | $512,000 | $7,488,000 | 25 | Jun 8, 2015 | sec.gov |
| Feb 29, 2016 | New notice | Indefinite | $0 | Indefinite | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nick Deslar Henderson | Executive Officer | |
| Joseph Deslar Kittle | Executive Officer | |
| Noel Douglas Martin | Executive Officer |
Other pharmaceuticals companies in Ohio that filed recently
- EIKONOKLASTES THERAPEUTICS, INC. $16.1 million · Oct 6, 2026
Every Form D from the week of Feb 27, 2017 · All recent filings in Ohio · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Lattice Biotech, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.